Explore professionally built ETF model portfolios. Discover now →
iShares Genomics Immunology and Healthcare ETF
IDNA performance and flow charts
Performance
Flows
Historic performance and flows
Data as of September 8, 2026| 1M | 3M | YTD | 1Y | 3Y | 5Y | |
|---|---|---|---|---|---|---|
| Perf. | +11.08% | +35.36% | +50.00% | +73.00% | +82.58% | -24.07% |
| Flows | +$27M | +$41M | +$56M | +$56M | +$35M | +$26M |
Characteristics
The iShares Genomics Immunology and Healthcare ETF is built to track the NYSE FactSet Global Genomics and Immuno Biopharma Index NTR - USD. This ETF provides physical exposure - by owning its shares you earn the return of the securities composing the index (as the ETF holds them directly). This share class generates a stream of income by distributing dividends.
| Management strategy | Passive |
| Strategy | Long Only |
| Provider | iShares |
| N° of holdings | 48 |
| Replication method | Direct (Physical) |
| Asset class | Equity |
| Dividend policy | Distributing |
Trailing 12m distribution yield | Join for free |
| Inception date | June 11, 2019 |
| ESG | No |
More data and info about IDNA on Trackinsight
Exposure
Data as of July 31, 2026Diversification
Total weight of top 15 holdings out of 48
Top 15 Holdings
Sectors
Countries
Similar ETFs
Trading data
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | |
|---|---|---|---|---|
| Volatility | +36.93% | +27.83% | +25.59% | +28.63% |
Max drawdown | -8.02% | -10.60% | -29.33% | -68.19% |
Max drawdown duration | 33d | 46d | 347d | 1815d |
Time to recover | 15d | 18d | 200d | N/A |
Replication quality
Data as of August 31, 2026Create an account to view replication metrics
1 year cumulative return difference | |
|---|---|
| Best | Join for free |
| Worst | Join for free |
| daily return difference | |
|---|---|
| Average | Join for free |
| Worst | Join for free |
What type of ETF is IDNA?
IDNA is a Passive ETF that provides exposure to Equity assets. It is managed by iShares.
What index does IDNA track?
IDNA tracks the NYSE FactSet Global Genomics and Immuno Biopharma Index NTR - USD, aiming to replicate its performance through full replication.
What does IDNA invest in?
This ETF provides exposure to Equities. It is part of the segment: BioTech & Genomics.
What is the expense ratio of IDNA?
The total expense ratio (TER) of IDNA is 0.47%, representing the annual fee charged by the fund manager.
When was IDNA launched?
IDNA was launched on June 11, 2019, marking its entry into the ETF market.
Who is the issuer of IDNA?
IDNA is issued by iShares.
What is the AUM of IDNA?
As of September 8, 2026, IDNA manages $258.12 M, reflecting the total assets held in the fund.
How has IDNA performed recently?
As of September 8, 2026, IDNA delivered a return of 11.08% over the past month (1M performance), 35.36% over the past three months (3M), and 50% year-to-date (YTD).
What are the recent fund flows for IDNA?
As of September 8, 2026, IDNA has seen net flows of +$27M in the past month (1M flow) and +$56M year-to-date (YTD).
Does IDNA pay dividends?
As of September 8, 2026, IDNA has a trailing 12-month distribution yield of 0.72%.
How many holdings are in IDNA
As of July 31, 2026, IDNA holds 48 securities in its portfolio. This level of diversification can influence the fund’s risk profile and exposure to individual assets.
How diversified is IDNA?
As of July 31, 2026, IDNA holds 48 securities, with 61.45% of its assets concentrated in its top 15 holdings.
What are the top holdings of IDNA?
As of July 31, 2026, IDNA holds a portfolio of 48 underlyings, with its largest positions including Bayer AG, Twist Bioscience Corp. and Revolution Medicines, Inc.. These top holdings play a significant role in shaping the fund’s performance and exposure.
What countries or regions does IDNA invest in?
As of July 31, 2026, IDNA has its largest geographic exposures in USA, Germany and France.
What sectors or themes does IDNA focus on?
As of July 31, 2026, IDNA is primarily exposed to Healthcare.
Advantages of ETFs over Mutual Funds1/6
Lower Costs
In this guide, we'll explore the advantages of ETFs over mutual funds, giving you valuable insights into why ETFs have gained significant popularity among investors like yourself.
Leveraged ETFs: Unlocking the Potential for Amplified Returns1/6
Understanding Leveraged ETFs
Explore leveraged ETFs: potential for amplified returns & risks. 5 ETFs to consider across equities, commodities & fixed income.
What is a Leveraged ETF?1/6
Introducing Leveraged and Inverse ETFs
In this guide, we'll dive into the world of leveraged ETFs, exploring their definition, mechanics, potential risks, and rewards.
Recent educational content
ETF Trends
ETF Industry KPIs September 8, 2026
This week’s KPI data overview highlights key metrics and trends shaping the ETF landscape.
ETF Trends
ETF Industry KPIs August 31, 2026
This week’s KPI data overview highlights key metrics and trends shaping the ETF landscape.
ETF Trends
ETF Industry KPIs August 24, 2026
This week’s KPI data overview highlights key metrics and trends shaping the ETF landscape.
What’sTheFund
What's the Fund | Ocean Park Diversified Income ETF (DUKZ)
James St Aubin, Chief Investment Officer at Ocean Park Asset Management, discuss the DUKZ ETF, exposing investors to the whole spectrum of asset classes in the fixed income markets, through their rules-based process.
Browse all educational columns
Have you tried our ETF Compare tool?
Compare ETFs like a pro. Analyze fees, performance, exposure & holdings side-by-side.